EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Mechanism of and research progress on alterations in the RET gene in thyroid cancer (Review)

Meng Wei, Rui Wang, Jincan Qian, Qiang Fang, Jun Tao

Molecular Medicine Reports · 02.04.2026 · 33 (6) · 1-9

DOI: 10.3892/mmr.2026.13874 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Medicine Reports, online erschienen am 02.04.2026. Verfasst von Meng Wei und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, P.R. China. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-ret, Thyroid Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The global incidence of thyroid cancer (TC) has markedly increased in recent years, making it the most prevalent endocrine‑related cancer worldwide. TC primarily originates from follicular and parafollicular cells of the thyroid gland, and includes four main pathological types: Papillary TC (PTC), follicular TC, medullary TC (MTC) and anaplastic TC. Notably, characteristic oncogenes and tumor suppressor genes are associated with TC, which are considered targets for the development of treatment strategies. The rearranged during transfection (RET) gene serves a pivotal role in the development of TC, and mutations and fusions of this gene are closely associated with the onset of MTC and PTC. The structure of RET includes four cadherin‑like domains and 16 cysteine residues in its extracellular domain, which confer unique functionalities and contribute to its intracellular role. RET activation is a complex process involving multiple intracellular events, including calcium ion binding, glial cell line‑derived neurotrophic factor family ligand binding, and RET receptor aggregation, dimerization and autophosphorylation. The present study reviews the structure and function of the RET proto‑oncogene and its pathogenic roles in various TC subtypes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-retThyroid NeoplasmsHumansProto-Oncogene MasMutationAnimals

Stichwörter der Autor:innen

RETgenemechanismprotein structurethyroid cancer

Substanzen

Proto-Oncogene Proteins c-retProto-Oncogene MasMAS1 protein, humanRET protein, human

Autor:innen und Institutionen

  • Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, P.R. China.
  • Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, P.R. China.
  • First Clinical Medical College, Anhui Medical University, Hefei, Anhui 230022, P.R. China.
  • Department of Scientific Research, The First Hospital of Anhui University of Science and Technology, Huainan, Anhui 232007, P.R. China.

Zitieren

APA

Wei, M., Wang, R., Qian, J., Fang, Q., & Tao, J. (2026). Mechanism of and research progress on alterations in the RET gene in thyroid cancer (Review). Molecular Medicine Reports, 33(6), 1-9. https://doi.org/10.3892/mmr.2026.13874

Vancouver

Wei M, Wang R, Qian J, Fang Q, Tao J. Mechanism of and research progress on alterations in the RET gene in thyroid cancer (Review). Molecular Medicine Reports. 2026;33(6):1-9. doi:10.3892/mmr.2026.13874

BibTeX
@article{Wei2026,
  author = {Wei, Meng and Wang, Rui and Qian, Jincan and Fang, Qiang and Tao, Jun},
  title = {Mechanism of and research progress on alterations in the RET gene in thyroid cancer (Review)},
  journal = {Molecular Medicine Reports},
  year = {2026},
  volume = {33},
  number = {6},
  pages = {1--9},
  doi = {10.3892/mmr.2026.13874}
}
Kostenlos starten →